Allan May

Overview

Allan May is a prominent angel investor based in Redwood City, California, with a focus on early-stage medical device and life science startups. He co-founded Life Science Angels, the largest angel organization in the U.S. dedicated solely to these sectors, which has invested over $35 million in 32 companies since 2005. The organization has attracted more than $700 million in follow-on venture capital and achieved five favorable exits. In 2011, Allan initiated the Life Science Angel Network, a syndicate of angel groups across the U.S., aiming to enhance the syndication and capitalization of highly vetted medical device and biotech startups. In 2007, Allan co-founded Emergent Medical Partners, a boutique venture fund focused on early-stage medical device company creation and investment. The fund has made 25 investments to date, with four successful exits, including eValve and Ardian. Allan has also served as Chairman of the Board of the Kauffman Foundation’s Angel Capital Education Foundation, now known as the Angel Resource Institute, a nonprofit dedicated to promoting and studying angel investing. Throughout his career, Allan has been a founder, chairman, CEO, or investor in over 50 medtech and biotech startups, including Athenagen (now Comentis), Nanostim, nSpine, and BioMimedica. He frequently lectures at universities, conferences, and government programs on trends and developments affecting early-stage biotech and medtech investing. Allan co-chaired Singularity University’s Innovation and Entrepreneurship Track at its 2011 FutureMed Program and is a member of the editorial board of Elsevier Windhover’s In Vivo magazine.

Investment Focus

• Innovative medical device or biotech solutions
• Strong management teams
• Scalable business models
• Potential for significant market impact

Portfolio Companies